Investigator initiated study for comparison of ART outcome in 0.2 mg GnRH agonist trigger
- Conditions
- Health Condition 1: O090- Supervision of pregnancy with history of infertility
- Registration Number
- CTRI/2022/07/044258
- Lead Sponsor
- Indira IVF Hospital Udaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Age 25- 40 years
2. Antral follicle count on day 2 of menses less than 5
3.AMH less than 1.2 ng per dl
1. BMI; >= 30 kg/m2
2. Presence of endocrine disorders; (uncontrolled diabetes mellitus, / hyperprolactinemia, thyroid dysfunction,
3. Congenital adrenal hyperplasia, Cushing syndrome, or polycystic ovary syndrome
4. Previous major uterine surgery
5. Donor oocyte cycle.
6. Gestational carrier
7. Fertility preservation.
8. Adenomyosis
9. Endometriosis
10. Premature ovarian failure.
11. Thin endometrium <6mm after 21 days of HRT (oestradiol valerate).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of mature oocytes retrieval <br/ ><br> <br/ ><br>Timepoint: On the day of ovum pick-up <br/ ><br>10- 15 days of start of simulation <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Follicle oocyte index <br/ ><br>Timepoint: On the day of ovum pick-up <br/ ><br>10- 15 days of start of simulation;Clinical pregnancy rateTimepoint: 4-6 weeks after embryo transfer;Implantation rateTimepoint: 4- 6 weeks after embryo transfer;OHSS occurrence rateTimepoint: 4 weeks from ovum pick up;Ongoing pregnancy rateTimepoint: 12th week of gestation;Oocyte retrieval rateTimepoint: On the day of ovum pick-up <br/ ><br>10- 15 days of start of simulation